MedicalSystem Biotechnology, CO. Ltd

No. 299 Qiming South Road, Yinzhou District
Ningbo,  Zhejiang  31504

China
https://www.nbmedicalsystem.com
  • Booth: 355

We are the leading IVD company in China focused in IVD products manufacuring and central commerical labs. We are a IFCC member since 2010. Currently, we own more than 20 group central labs and reference labs in China, 3 reaserch center in China and 1 R&D center in San diego,CA. In 2016, We acquired Atherotech diagnostic labs based in Alabama, USA. We are certified by ISO9001,ISO13485,ISO15189 and CE.


 Press Releases

  • MedicalSystem Biotechnology Co., Ltd. is a national high-tech enterprise specializing in the research and development, production,sales and service of medical diagnostic products. The company was founded in 2003, standing in Ningbo, the seashore of the East China Sea. In 2015, it was successfully listed on the GEM of Shenzhen Stock Exchange.

    The main industries of MedicalSystem are in vitro diagnostic reagents, instruments and independent third party medical diagnostic services.At present, we have obtained 400+ registration certificates of in vitro diagnostic reagents and 50+ registration certificates of diagnostic instruments. Our product lines cover biochemistry, chemiluminescence,hematology, urine, mass spectrometry, molecular diagnosis, blood lipid subcomponent detection VAP and POCT, etc. We are one of suppliers in the IVD industry who can provide diagnostic reagents and diagnostic instruments at the same time. MedicalSystem adheres to the strategy of "in vitro diagnostic instruments as engine, in vitro diagnostic products as core, in vitro diagnostic products + diagnostic services for common development", and constantly improves the innovation ability and diagnostic service level of the three major technologies of product raw materials, reagents and instruments, so as to enhance the comprehensive competitiveness of the company.
  • Product Highlights

    1. MS-630 – Compact and cost-effective

      • 3-part differential for routine testing.

      • High throughput: Up to 60 samples/hour.

      • Ideal for small clinics and primary labs.

    2. MS-650 – Enhanced mid-range model

      • 5-part WBC differentiation .

      • High throughput: Up to 60 samples/hour.

      • Workflow efficiency.

    3. MS-655 – Advanced automation

      • 5-part differentiation + 29 parameters 

      • 90 samples per hour

      • Designed for medium-to-large labs.

    4. MS-668 – 5-part fully auto hematology analyzer

      • 33 parameters .

      • Automatic loading

      • 90 samples/hour throughput


    Why Choose MedicalSystem?

    ✅ Reliability: The company maintains steady growth.
    ✅ Smart Tech: AI-driven analysis minimizes errors.
    ✅ Global Support: one-stop service network in Global marketing;.
    ✅ Cost Savings: Low reagent consumption & maintenance.

  • Fully Automated Biochemistry Analyzer MS-380P,A compact and stable biochemical analyzer, providing accurate and high efficient all-in-one solutions for small and medium-sized laboratories.
    • Throughput:300T/H(constant speed), 300T/H for ISE
    • Size:865mm(L)x600mm(W)x500mm(H)
    • Sample positions:Expandable up to 80 positions
    • Reagent positions:Up to 80 positions
    • Multi bottles:Acceptable for 4 sizes of reagent bottles: 20ml, 40ml, 60ml and 70ml
    • Optical system:Post-filter spectroscopy system, 340-850nm,12 wavelengths
    • Water supply requirements:300T/H5L/H240T/H <3L/H
  • To help laboratories maximize space and enhance operational efficiency, MedicalSystem proudly introduces the newly upgraded MS-i2280 automatic chemiluminescence immunoassay analyzer. Powered by a cutting-edge acridinium ester platform and proprietary micro-scale small molecule detection technology, the MS-i2280 offers seamless integration of reagents and instrumentation—delivering faster, more accurate, and more reliable diagnostic performance.

    MS-i2280, covering an area less than 1m2, provides a better laboratory experience with more dexterous bulk, superior performance and streamlined maintenance; and supports intelligent expansion to meet the needs of clinical laboratories in medical institutions at all levels.
     
  • MedicalSystem Biotechnology Co., Ltd. is a national high-tech enterprise specializing in the R&D, production, sales, and service of in vitro diagnostic (IVD) products. Listed on the Shenzhen Stock Exchange (SZSE: 300439) since 2015, the company focuses on IVD reagents, instruments, and independent third-party diagnostic services.
     
    In 2016, MedicalSystem acquired Atherotech Diagnostics Lab (USA), bringing the VAP technology to China. Approved by the NMPA in 2019, this innovation supports early detection and intervention of dyslipidemia, helping reduce cardiovascular risk.

    For inquiries, please contact our sales representatives on-site at the exhibition or via online channels.